Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trial.
Leikas AJ, Hartikainen JEK, Kastrup J, Mathur A, Gyöngyösi M, Fernández-Avilés F, Sanz-Ruiz R, Wojakowski W, Gwizdała A, Luite R, Nikkinen M, Qayyum AA, Haack-Sørensen M, Kelham M, Jones DA, Hamzaraj K, Spannbauer A, Fernández-Santos ME, Jędrzejek M, Skoczyńska A, Vartiainen N, Knuuti J, Saraste A, Ylä-Herttuala S.
Leikas AJ, et al. Among authors: jones da.
Open Heart. 2024 Oct 17;11(2):e002817. doi: 10.1136/openhrt-2024-002817.
Open Heart. 2024.
PMID: 39424303
Free PMC article.
Clinical Trial.